Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor
To the Editor: In their Research Letter, Dr Chaisson and colleagues,1 using data from an ongoing study,2 address the uncertainty of the timing of antiretroviral treatment initiation,3,4 and conclude that both CD4 cell counts and viral load should be considered in deciding when to initiate antiretroviral therapy.
Kyriakides TC, Guarino P. Timing of Antiretroviral Treatment Initiation. JAMA. 2001;285(13):1702–1703. doi:10.1001/jama.285.13.1702
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: